Inmd stock

Top Analyst Stocks Popular. Bitcoin Popular. Gold New.

Top Analyst Stocks Popular. Bitcoin Popular. Gold New. Unusual Options Activity Popular. Research Tools.

Inmd stock

.

Copying Jeff Johnson 's trades and holding each position for 1 Year would result in

.

Search markets. News The word News. My Watchlist. Business Insider logo The words "Business Insider". Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Home Stocks InMode-stock. InMode Ltd.

Inmd stock

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Morningstar brands and products. Investing Ideas. As of Mar 8, pm Delayed Price Closed. Unlock our analysis with Morningstar Investor. Start Free Trial. INMD is trading within a range we consider fairly valued. Mar 8, Fair Value.

Tundra troca

Price Target Upside Mortgage Calculator Popular. Stock Splits. Stock Buybacks. Compare ETFs. Federal Funds Rate. Standard Deviation 0. InMode does not currently pay dividends. Top Smart Score Stocks Popular. Compare Stocks. Currency Center.

InMode produces medical equipment, including devices purporting to offer body sculpting and other rejuvenation technologies. For more information, submit a form , email attorney Aaron Dumas, Jr.

About Us. InMode has a conensus rating of Moderate Buy which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings. Stock Screener. Following the earnings report the stock price went down Neutral 9 Bullish. Top Insiders Stocks. Compare ETFs. Dividend Stock Comparison New. Daily Analyst Ratings. Follow the analysts of your choice to receive real-time updates when they publish a new rating. Hedge Fund Trend Decreased. Momentum Follow Us. Rating Consensus Moderate Buy. Shares Outstanding 83,,